Yoshimitsu Taguchi

Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate

Takeshi Yabu, Hidekazu Tomimoto, Yoshimitsu Taguchi et al. · Blood · 2005 · 137 citations

Ceramide Reduction and Transcriptional Up-Regulation of Glucosylceramide Synthase through Doxorubicin-Activated Sp1 in Drug-Resistant HL-60/ADR Cells

Yoshikazu Uchida, Mitsuru Itoh, Yoshimitsu Taguchi et al. · Cancer Research · 2004 · 71 citations

Increase of Nuclear Ceramide through Caspase-3-Dependent Regulation of the “Sphingomyelin Cycle” in Fas-Induced Apoptosis

Mitsumasa Watanabe, Toshiyuki Kitano, Tadakazu Kondo et al. · Cancer Research · 2004 · 64 citations · Full text

Oncogenic Determination of a Broad Spectrum of Phenotypes of Hepatocyte-Derived Mouse Liver Tumors

Masahiro Yamamoto, Xin Bing, Kenji Watanabe et al. · American Journal Of Pathology · 2017 · 59 citations · Full text

Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase

Yoshimitsu Taguchi, Tadakazu Kondo, Mitsumasa Watanabe et al. · Blood · 2004 · 50 citations · Full text